Drug Information

Drug General Information
Drug ID
D0T0RI
Former ID
DNC010165
Drug Name
JNJ-28318706
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530360]
Structure
Download
2D MOL

3D MOL
Formula
C29H31N3O4
Canonical SMILES
CC(C1=CC=CC=C1)N2CCN(CC2)C3=CC=CC4=C3C(=O)N(C4=O)CC5=CC<br />(=C(C=C5)OC)OC
InChI
1S/C29H31N3O4/c1-20(22-8-5-4-6-9-22)30-14-16-31(17-15-30)24-11-7-10-23-27(24)29(34)32(28(23)33)19-21-12-13-25(35-2)26(18-21)36-3/h4-13,18,20H,14-17,19H2,1-3H3/t20-/m1/s1
InChIKey
XVYISGJLURJDNX-HXUWFJFHSA-N
PubChem Compound ID
23627612
Target and Pathway
Target(s) Urotensin II receptor Target Info Inhibitor [530360]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (q) signalling events
WikiPathways Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530360J Med Chem. 2009 Dec 10;52(23):7432-45.Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.
Ref 530360J Med Chem. 2009 Dec 10;52(23):7432-45.Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.